V8 Peptides — Engineered Performance
Research Library
KPV Peptide Explained: Sequence, Structure and Pathways
KPVChemistry

KPV Peptide Explained: Sequence, Structure and Pathways

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What is the KPV peptide, structurally? KPV is the tripeptide Lys-Pro-Val, residues 11-13 of α-MSH, with formula C16H30N4O4 and a molecular weight of about 342.4 g/mol. It has no folded structure; preclinical work links it to NF-κB signaling, PepT1 uptake and in vitro antimicrobial effects. For laboratory research use only.

KPV is a three-letter code for three amino acids, and nearly everything notable about it comes from where those three sit in a larger molecule. This article walks from sequence to structure to pathway: where Lys-Pro-Val lies in α-MSH, what is lost when the other ten residues are removed, how a tripeptide can be both small and biologically active in published assays, and which pathways the preclinical work attaches to it. For laboratory research use only; not for human consumption.

The product is described on the KPV research vials page: a lyophilized Lys-Pro-Val tripeptide with molecular formula C16H30N4O4, supplied as 5 mg and 10 mg vials at ≥98% HPLC purity. For the overall research picture, see the KPV research overview; for a plain definition, what is KPV; for notation, understanding amino acid sequences.

Sequence: reading Lys-Pro-Val

The one-letter code KPV stands for lysine, proline and valine, read from the N-terminus to the C-terminus. Lysine carries a positively charged side-chain amino group at physiological pH; proline is the only proteinogenic amino acid whose side chain loops back to the backbone nitrogen, which restricts the backbone's flexibility; valine is a small hydrophobic residue at the free C-terminal end. The molecular formula C16H30N4O4 corresponds to a molecular weight of about 342.4 g/mol, so the peptide is smaller than most dyes and many drug fragments.

Position in KPVResiduePosition in α-MSH(1-13)Notable property
1 (N-terminal)Lysine (K)11Basic, positively charged side chain
2Proline (P)12Cyclic side chain restricts backbone rotation
3 (C-terminal)Valine (V)13Small hydrophobic residue; free carboxyl end

Where it comes from: the α-MSH precursor

α-MSH is a tridecapeptide, SYSMEHFRWGKPV, derived from the precursor proopiomelanocortin, and it belongs to the melanocortin family of peptides [1, 4]. KPV is its C-terminal end, residues 11-13. The melanocortin system as a whole comprises five G protein-coupled receptors, peptide agonists from the same precursor and endogenous antagonists, and regulates functions ranging from pigmentation to energy homeostasis [2]. Within α-MSH, the central sequence His-Phe-Arg-Trp (residues 6-9) is described as the invariant melanocortin core, whereas Lys-Pro-Val (11-13) was identified as important for antimicrobial activity [3].

The division of labor matters. The N-terminal and core regions carry the receptor-recognition features, and a review of α-MSH and related tripeptides notes that the C-terminal tripeptide preserved anti-inflammatory effects while lacking the pigmentary action of the whole hormone [1]. KPV is therefore a fragment studied to ask which activities of α-MSH can be traced to its tail alone.

Structure: what a tripeptide can and cannot have

A tripeptide has no tertiary structure. It does not fold, form helices or hold a binding pocket, and in solution it exists as an ensemble of conformations. Two features still shape its behavior. The proline in position 2 introduces a peptide bond that can occur in cis or trans form, giving more than one backbone shape, and the charged lysine and the free carboxyl group give the molecule a net positive character at neutral pH. The practical consequences are mundane: KPV is very soluble, it runs early in reversed-phase HPLC, and it is chemically straightforward to make and check, which the article on KPV chemistry and synthesis covers.

The α-MSH fragment work gives a more detailed view for longer analogs. A conformational study of α-MSH(6-13) analogs in membrane-mimetic micelles observed different turn structures in peptides of different activity and built a conformation-activity model [3]. Because KPV is only the 11-13 portion, that detail applies to the larger analogs and not directly to the tripeptide.

Pathways the preclinical work attaches to KPV

Pathway or processWhat was reportedSource
NF-κB signalingThe parent hormone abolished TNF-mediated NF-κB activation, with IκBα degradation and p65 translocation inhibited [5]; KPV reduced NF-κB reporter activity and p65 nuclear translocation in cell models [6, 7][5, 6, 7]
Peptide transportKPV uptake via PepT1 in intestinal epithelial and immune cells[6]
Cytokine and mediator secretionReduced IL-8, eotaxin, MMP-9 activity and other mediators in airway and gut-cell models[7, 6]
Antimicrobial effects in vitroReduced S. aureus colony formation and C. albicans viability for α-MSH and KPV[4]
Melanocortin receptorsActivation of MC1R and MC3R was proposed in preclinical work to control inflammation for melanocortin peptides generally[8]

The last row needs caution. The receptor story belongs to the melanocortin family; whether KPV itself relies on those receptors is partly answered in the negative by work in airway cells and in MC1R-deficient mice [7], as described in the NF-κB article.

What the sequence does not tell you

Sequence is a necessary part of identity and a poor guide to function. Three examples from this literature show the limits. First, the same C-terminal fragment is reported in different assays to inhibit inflammatory signaling in epithelial cells and to reduce survival of microbes, with the antimicrobial effect suggested to involve cAMP in yeast [4], so one sequence has more than one reported activity, and the activities should not be merged. Second, substitution of a single residue changes potency in analogs: the keratinocyte work compared KPV with an analog containing D-valine at the third position, and both inhibited the pathway [9]. Third, activity in a cell line does not guarantee activity in a tissue.

From sequence to a lab record

For the bench, the sequence leads to a handful of numbers. The molecular weight (about 342.4 g/mol) converts between mass and molar concentrations: molar concentration equals mass concentration divided by molecular weight. The stock concentration equals vial mass divided by diluent volume, which the reconstitution calculator does for any lot. The identity claim, that the peptide in the vial is Lys-Pro-Val, rests on the analytical documentation, and a chromatogram purity figure does not by itself confirm sequence; understanding HPLC purity and HPLC vs mass spectrometry explain the difference, and how to read a COA covers the fields on a certificate. Batch documentation, where published, is on the COA page.

Related tripeptides, for context

KPV is not the only tripeptide studied for biological activity. The α-MSH review that singled out KPV also describes KdPT, a derivative corresponding to amino acids 193-195 of IL-1β, as another tripeptide with anti-inflammatory effects, and it notes that the physicochemical properties and expected low production costs of both made them attractive as research subjects [1]. Another well-known tripeptide in the V8 catalog is the copper-binding GHK, whose research is entirely different in subject matter; the comparison is made in GHK-Cu vs KPV. Putting the three side by side shows that tripeptide size alone does not define activity: each derives from a different protein, with a different reported biology.

The common feature is practical rather than biological. Tripeptides are easy to synthesize and characterize, they dissolve readily, and they are the largest peptides that the PepT1 transporter accepts, a point that makes uptake experiments straightforward to frame [10]. They are also fragile in one respect: short peptides are readily cleaved by exopeptidases in biological media, so a result in a protease-rich medium needs a stability check on the peptide itself before it is attributed to the intact sequence. Any lab record for a tripeptide experiment should state the medium, the incubation time and whether intact peptide was confirmed at the end.

Questions the sequence invites

  1. Which residue matters? Alanine-scanning-style experiments, in which each position is replaced in turn, are the standard way to answer it. The published α-MSH analog studies used substitutions for this purpose [3, 9].
  2. Does stereochemistry matter? The D-valine analog comparison in keratinocytes is an example of how it can be tested [9].
  3. Is the C-terminal carboxyl important? Amidation versus a free acid changes charge and could change transporter recognition, and PepT1 transport is described as enantio-selective [10].
  4. Does a longer sequence help? The α-MSH(6-13) analogs show that adding core residues changes potency in antimicrobial assays [3].

Frequently asked questions

What does KPV stand for?

Lysine, proline and valine, the one-letter codes for the three amino acids in the sequence Lys-Pro-Val.

Where does KPV come from?

It is residues 11-13, the C-terminal end, of α-MSH, a 13-residue melanocortin peptide derived from proopiomelanocortin.

What is the molecular weight of KPV?

About 342.4 g/mol, from the molecular formula C16H30N4O4 listed on the product page.

Does KPV have a defined three-dimensional structure?

No. A tripeptide does not fold into a stable tertiary structure; it exists as a set of conformations in solution.

Why is proline important in the sequence?

Its cyclic side chain restricts the backbone and allows cis and trans peptide bonds, which gives the sequence a particular shape and chemistry.

Is KPV the active part of α-MSH?

Published work reports that the C-terminal tripeptide retains anti-inflammatory effects without the pigmentary action, and that C-terminal fragments retain antimicrobial effects in vitro.

Does KPV act through melanocortin receptors?

In some systems it appears to act partly independently of them, for example in MC1R-deficient mice and in airway epithelial cells.

Which pathways have been studied?

NF-κB and MAP kinase signaling, peptide transport via PepT1, cytokine secretion and in vitro antimicrobial assays.

Can the sequence prove identity of a vial?

No. Identity needs analytical confirmation, and a purity chromatogram alone does not establish sequence.

How do I convert between mass and molar concentration?

Divide mass concentration by molecular weight, using about 342.4 g/mol for KPV.

Related reading: KPV Lab Handling: Reconstitution and Storage Steps, KPV Tripeptide Chemistry: Formula, Synthesis, Analysis, KPV Tripeptide Research Guide: Evidence and Gaps.

References

  1. Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. α-Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effects in Vitro and in Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases. Endocrine Reviews. 2008;29(5):581-602. doi:10.1210/er.2007-0027
  2. Cone RD. Studies on the Physiological Functions of the Melanocortin System. Endocrine Reviews. 2006;27(7):736-749. doi:10.1210/er.2006-0034
  3. Carotenuto A, Saviello MR, Auriemma L, Campiglia P, Catania A, Novellino E, et al. Structure–function Relationships and Conformational Properties of α‐MSH(6–13) Analogues with Candidacidal Activity. Chem Biol Drug Des. 2007;69(1):68-74. doi:10.1111/j.1747-0285.2007.00473.x
  4. Cutuli M, Cristiani S, Lipton JM, Catania A. Antimicrobial effects of α-MSH peptides. Journal of Leukocyte Biology. 2000;67(2):233-239. doi:10.1002/jlb.67.2.233
  5. Manna SK, Aggarwal BB. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol. 1998;161(6):2873-2880. PMID: 9743348
  6. Dalmasso G, Charrier–Hisamuddin L, Thu Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Gastroenterology. 2008;134(1):166-178. doi:10.1053/j.gastro.2007.10.026
  7. Land SC. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. Int J Physiol Pathophysiol Pharmacol. 2012;4(2). PMID: 22837805
  8. Catania A, Gatti S, Colombo G, Lipton JM. Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation. Pharmacological Reviews. 2004;56(1):1-29. doi:10.1124/pr.56.1.1
  9. Moustafa M, Helen Kemp E, MacNeil S, Szabo M, Haycock JW, Ghanem GE, et al. Inhibition of Tumor Necrosis Factor-α Stimulated NFκB/p65 in Human Keratinocytes by α-Melanocyte Stimulating Hormone and Adrenocorticotropic Hormone Peptides. Journal of Investigative Dermatology. 2002;119(6):1244-1253. doi:10.1046/j.1523-1747.2002.19602.x
  10. Daniel H. Molecular and Integrative Physiology of Intestinal Peptide Transport. Annu. Rev. Physiol.. 2004;66(1):361-384. doi:10.1146/annurev.physiol.66.032102.144149

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.